189 related articles for article (PubMed ID: 8902408)
1. Comparative in vitro activity of quinupristin/dalfopristin against multidrug resistant Enterococcus faecium.
Bonilla HF; Perri MB; Kauffman CA; Zervos MJ
Diagn Microbiol Infect Dis; 1996 Jul; 25(3):127-31. PubMed ID: 8902408
[TBL] [Abstract][Full Text] [Related]
2. Synergy testing of vancomycin-resistant Enterococcus faecium against quinupristin-dalfopristin in combination with other antimicrobial agents.
Matsumura SO; Louie L; Louie M; Simor AE
Antimicrob Agents Chemother; 1999 Nov; 43(11):2776-9. PubMed ID: 10543762
[TBL] [Abstract][Full Text] [Related]
3. Characterization of vancomycin-resistant Enterococcus faecium isolates from the United States and their susceptibility in vitro to dalfopristin-quinupristin.
Eliopoulos GM; Wennersten CB; Gold HS; Schülin T; Souli M; Farris MG; Cerwinka S; Nadler HL; Dowzicky M; Talbot GH; Moellering RC
Antimicrob Agents Chemother; 1998 May; 42(5):1088-92. PubMed ID: 9593132
[TBL] [Abstract][Full Text] [Related]
4. In-vitro bactericidal activity of quinupristin/dalfopristin alone and in combination against resistant strains of Enterococcus species and Staphylococcus aureus.
Kang SL; Rybak MJ
J Antimicrob Chemother; 1997 May; 39 Suppl A():33-9. PubMed ID: 9511060
[TBL] [Abstract][Full Text] [Related]
5. Bactericidal and inhibitory activity of quinupristin/dalfopristin against vancomycin- and gentamicin-resistant Enterococcus faecium.
Hill RL; Smith CT; Seyed-Akhavani M; Casewell MW
J Antimicrob Chemother; 1997 May; 39 Suppl A():23-8. PubMed ID: 9511058
[TBL] [Abstract][Full Text] [Related]
6. Treatment of vancomycin-resistant Enterococcus faecium with RP 59500 (quinupristin-dalfopristin) administered by intermittent or continuous infusion, alone or in combination with doxycycline, in an in vitro pharmacodynamic infection model with simulated endocardial vegetations.
Aeschlimann JR; Zervos MJ; Rybak MJ
Antimicrob Agents Chemother; 1998 Oct; 42(10):2710-7. PubMed ID: 9756782
[TBL] [Abstract][Full Text] [Related]
7. In vitro activity of quinupristin/dalfopristin and other antibiotics against ampicillin-resistant enterococcus faecium.
Wang FD; Liu IM; Liu CY
Zhonghua Yi Xue Za Zhi (Taipei); 2000 Feb; 63(2):119-23. PubMed ID: 10677922
[TBL] [Abstract][Full Text] [Related]
8. Antimicrobial activity of quinupristin-dalfopristin combined with other antibiotics against vancomycin-resistant enterococci.
Eliopoulos GM; Wennersten CB
Antimicrob Agents Chemother; 2002 May; 46(5):1319-24. PubMed ID: 11959562
[TBL] [Abstract][Full Text] [Related]
9. [Vancomycin-resistant enterococci: in vitro activity of quinupristin / dalfoprostin (RP 59500)].
Betriu C; Valverde JF; Culebras E; Gómez M; Sánchez A; Palau ML; Picazo JJ
Enferm Infecc Microbiol Clin; 1999; 17(7):335-9. PubMed ID: 10535185
[TBL] [Abstract][Full Text] [Related]
10. Effect of quinupristin/dalfopristin alone or in combination with vancomycin on the structure of Enterococcus faecium.
Lorian V; Fernandes F
Drugs Exp Clin Res; 1998; 24(2):73-6. PubMed ID: 9675547
[TBL] [Abstract][Full Text] [Related]
11. Treatment of vancomycin-resistant Enterococcus faecium infections with an investigational streptogramin antibiotic (quinupristin/dalfopristin): a report of fifteen cases.
Dever LL; Smith SM; Dejesus D; Masurekar M; Patel D; Kaminski ZC; Johanson WG
Microb Drug Resist; 1996; 2(4):407-13. PubMed ID: 9158811
[TBL] [Abstract][Full Text] [Related]
12. Comparative in-vitro activity of quinupristin/dalfopristin against Enterococcus spp.
Williams JD; Maskell JP; Whiley AC; Sefton AM
J Antimicrob Chemother; 1997 May; 39 Suppl A():41-6. PubMed ID: 9511061
[TBL] [Abstract][Full Text] [Related]
13. Effect of quinupristin/dalfopristin on the outcome of vancomycin-resistant Enterococcus faecium bacteraemia: comparison with a control cohort.
Linden PK; Pasculle AW; McDevitt D; Kramer DJ
J Antimicrob Chemother; 1997 May; 39 Suppl A():145-51. PubMed ID: 9511079
[TBL] [Abstract][Full Text] [Related]
14. Effects of genes encoding resistance to streptogramins A and B on the activity of quinupristin-dalfopristin against Enterococcus faecium.
Bozdogan B; Leclercq R
Antimicrob Agents Chemother; 1999 Nov; 43(11):2720-5. PubMed ID: 10543753
[TBL] [Abstract][Full Text] [Related]
15. [In vitro activities of quinupristin/dalfopristin in combination with vancomycin and gatifloxacin against Staphylococcus aureus and Enterococcus faecium clinical isolates].
Gülden E; Ermertcan S
Mikrobiyol Bul; 2009 Jan; 43(1):53-60. PubMed ID: 19334380
[TBL] [Abstract][Full Text] [Related]
16. The efficacy and safety of quinupristin/dalfopristin for the treatment of infections caused by vancomycin-resistant Enterococcus faecium. Synercid Emergency-Use Study Group.
Moellering RC; Linden PK; Reinhardt J; Blumberg EA; Bompart F; Talbot GH
J Antimicrob Chemother; 1999 Aug; 44(2):251-61. PubMed ID: 10473233
[TBL] [Abstract][Full Text] [Related]
17. Quinupristin-dalfopristin-resistant Enterococcus faecium on chicken and in human stool specimens.
McDonald LC; Rossiter S; Mackinson C; Wang YY; Johnson S; Sullivan M; Sokolow R; DeBess E; Gilbert L; Benson JA; Hill B; Angulo FJ
N Engl J Med; 2001 Oct; 345(16):1155-60. PubMed ID: 11642231
[TBL] [Abstract][Full Text] [Related]
18. Synergic activity of vancomycin-quinupristin/dalfopristin combination against Enterococcus faecium.
Lorian V; Fernandes F
J Antimicrob Chemother; 1997 May; 39 Suppl A():63-6. PubMed ID: 9511065
[TBL] [Abstract][Full Text] [Related]
19. Antimicrobial activity of quinupristin-dalfopristin (RP 59500, Synercid) tested against over 28,000 recent clinical isolates from 200 medical centers in the United States and Canada.
Jones RN; Ballow CH; Biedenbach DJ; Deinhart JA; Schentag JJ
Diagn Microbiol Infect Dis; 1998 Jul; 31(3):437-51. PubMed ID: 9635235
[TBL] [Abstract][Full Text] [Related]
20. Influence of inducible cross-resistance to macrolides, lincosamides, and streptogramin B-type antibiotics in Enterococcus faecium on activity of quinupristin-dalfopristin in vitro and in rabbits with experimental endocarditis.
Fantin B; Leclercq R; Garry L; Carbon C
Antimicrob Agents Chemother; 1997 May; 41(5):931-5. PubMed ID: 9145847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
